EICHOR
● Active Not Recruiting
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Condition: Breast Cancer, Early-Onset · Sponsor: Rutgers, The State University of New Jersey
About this study
Primary Objective: 1\) To examine the impact of Circulating tumor DNA (ctDNA) (expressed as mean tumor molecules per ml) on treatment decision making in patients with early stage breast cancer after neoadjuvant therapy and surgery Secondary Objectives: 1. Understand ctNDA kinetics in the neoadjuvant and adjuvant setting 2. To identify any associations between clinical staging and measurable ctDNA
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (12)
| Trinitas Hospital and Comprehensive Cancer Center | Elizabeth, New Jersey, United States | — |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | Hamilton, New Jersey, United States | — |
| Jersey City Medical Center | Jersey City, New Jersey, United States | — |
| Monmouth Medical Center - Southern Campus | Lakewood, New Jersey, United States | — |
| Cooperman Barnabas Medical Center | Livingston, New Jersey, United States | — |
| Monmouth Medical Center | Long Branch, New Jersey, United States | — |
| Robert Wood Johnson University Hospital | New Brunswick, New Jersey, United States | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick, New Jersey, United States | — |
| Newark Beth Israel Medical Center | Newark, New Jersey, United States | — |
| Robert Wood Johnson Barnabas Hospital -Somerset | Somerville, New Jersey, United States | — |
| Steeplechase Cancer Center | Somerville, New Jersey, United States | — |
| Monmouth Medical Center Vantage Point Infusion Cente | West Long Branch, New Jersey, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05333874